|
Press Releases |
|
 |
|
Tuesday, May 28, 2024 |
|
CR Pharmaceutical Armed with Leading Advantages Releases Growth Potential and Achieves High-quality Sustainable Development |
China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320.HK), recorded total revenue of RMB244,703.9 million last year, a 12.2% climb year-on-year, and net profit of RMB 7,775.0 million, a 16.8% increase year-on-year. more info >> |
|
Monday, November 14, 2022 |
|
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again |
China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022. more info >> |
|
Monday, January 20, 2020 |
|
安捷證券第二輪藥品集採結果:降價主旋律不變,首推創新型龍頭 |
2020年01月17日,第二輪國家集採正式開標,結果如下:122家企業參與採購,33個(按通用名計)藥品的194個品規激烈厮殺,價格降幅超出市場預期。 more info >> |
|
Tuesday, July 2, 2019 |
|
华润医药再度蝉联资本杰出中国企业成就奖 |
华润医药集团有限公司(「华润医药」或「集团」;股份编号:3320)欣然宣布,集团于《资本杂志》主办的第十四届「资本杰出中国企业成就奖」中再度获选为「资本杰出中国医药集团」,彰显集团在过去一年于业务上的杰出表现及其稳固的发展潜力。 more info >> |
|
華潤醫藥再度蟬聯資本傑出中國企業成就獎 |
華潤醫藥集團有限公司(「華潤醫藥」或「集團」;股份編號:3320)欣然宣佈,集團於《資本雜誌》主辦的第十四屆「資本傑出中國企業成就獎」中再度獲選為「資本傑出中國醫藥集團」,彰顯集團在過去一年於業務上的傑出表現及其穩固的發展潛力。 more info >> |
|
Friday, August 25, 2017 |
|
华润医药中期业绩增长理想 实现收益约港币827亿元 |
华润医药集团有限公司(「华润医药」)或「集团」;股份编号:3320)公布截至2017年6月30日止年度(「期内」)的中期业绩。 more info >> |
|
華潤醫藥中期業績增長理想 實現收益約港幣827億元 |
華潤醫藥集團有限公司(「華潤醫藥」)或「集團」;股份編號:3320)公佈截至2017年6月30日止年度(「期內」)的中期業績。 more info >> |
|
China Resources Pharmaceutical Delivers Solid Interim Results; Half-year Revenue Reaches HK$82.7 Billion |
China Resources Pharmaceutical Group Limited ("CR Pharmaceutical" or the "Group") (stock code: 3320), announced its interim results for the six months ended 30 June 2017 ("Reporting Period"). more info >> |
|
Monday, March 20, 2017 |
|
华润医药全年业绩稳健增长 实现收益约港币1,567亿元 |
华润医药集团有限公司(「华润医药」)或「集团」;股份编号:3320)公布截至2016年12月31日止年度(「年内」)的全年业绩。 more info >> |
|
華潤醫藥全年業績穩健增長 實現收益約港幣1,567億元 |
華潤醫藥集團有限公司(「華潤醫藥」)或「集團」;股份編號:3320)公佈截至2016年12月31日止年度(「年內」)的全年業績。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
親子暑假激FUN推介!新一代AI保險銷售平台HoldCover呈獻
Aug 8, 2025 21:01 HKT/SGT
|
|
|
Chinese Culinary Culture Training Programme: 30 Hong Kong Students Embarked on a Study Tour in Chaoshan
Aug 8, 2025 20:25 HKT/SGT
|
|
|
From Food Culture to Future Living: Shiology Makes Splash at HK Book Fair
Aug 8, 2025 20:18 HKT/SGT
|
|
|
Graid Technology Announces Global Availability of SupremeRAID(TM) HE (HPC Edition), Wins Best of Show at FMS 2025
Aug 8, 2025 20:06 HKT/SGT
|
|
|
U.S. Polo Assn. Named No. 1 Sports Licensor and Top 25 on License Global' Prestigious 'Top Global Licensors' List
Aug 8, 2025 20:04 HKT/SGT
|
|
|
International Land Alliance Brings Baja to Buyers with Live Zoom Webinar Experience
Aug 8, 2025 18:50 HKT/SGT
|
|
|
Intellifusion Submits an Application to List on the Hong Kong Stock Exchange: A National Breakthrough in AI Inference Chips
Aug 8, 2025 18:36 HKT/SGT
|
|
|
亲子暑假激FUN推介!新一代AI保险销售平台HoldCover呈献
Aug 8, 2025 18:27 HKT/SGT
|
|
|
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Aug 8, 2025 18:09 HKT/SGT
|
|
|
雲頂新耀耐賦康(R)擴產獲批 亞洲全域完全批准雙突破 加速邁向50億銷售峰值
Aug 8, 2025 18:09 HKT/SGT
|
|
|
云顶新耀耐赋康(R)扩产获批 亚洲全域完全批准双突破 加速迈向50亿销售峰值
Aug 8, 2025 18:09 HKT/SGT
|
|
|
WRC 2025: Shoucheng Showcases Full Robotics Value Chain
Aug 8, 2025 16:46 HKT/SGT
|
|
|
Qube Celebrates 20 Years of Business Events Impact with Industry Recognition and Vision for the Future
Aug 8, 2025 16:19: JST
|
|
|
消费场景持续丰富 锅圈计划五年内达成第二个万店目标
Aug 8, 2025 15:54 HKT/SGT
|
|
|
Qube Celebrates 20 Years of Business Events Impact with Industry Recognition and Vision for the Future
Aug 8, 2025 15:19 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|